Emerging Drug Safety Technology Program

ICR 202602-0910-003

OMB:

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
ICR Details
202602-0910-003
Received in OIRA
HHS/FDA CDER
Emerging Drug Safety Technology Program
New collection (Request for a new OMB Control Number)   No
Regular 03/27/2026
  Requested Previously Approved
36 Months From Approved
37 0
610 0
0 0

This ICR collects information from eligible parties who develop, leverage, or intend to leverage AI or other emerging technologies that can be used to satisfy the postmarketing reporting requirements in 21 CFR 314.80, 314.98, and 600.80 and would like to meet with CDER staff to discuss their research, development, and use of AI and other emerging technologies in PV. Eligible parties that are granted a meeting will submit additional information as instructed through the EDSTP via a meeting package.

US Code: 21 USC 355 Name of Law: FFDCA
   US Code: 42 USC 262 Name of Law: PHS Act
  
None

Not associated with rulemaking

  90 FR 29561 07/03/2025
91 FR 7501 02/18/2026
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 37 0 0 37 0 0
Annual Time Burden (Hours) 610 0 0 610 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new information collection.

$58,080
No
    Yes
    No
No
No
No
No
Ila Mizrachi 301 796-7726 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/27/2026

Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].

© 2026 OMB.report | Privacy Policy